Letter to the Editor
Positron emission tomography computed tomography in large cell transformation of mycosis fungoides
Thomas Cheng,
Thomas Cheng
Department of Radiology, Hong Kong Sanatorium Hospital, Hong Kong, China
Search for more papers by this author Florence Loong,
Florence Loong
Department of Pathology, Queen Mary Hospital, Hong Kong, China
Search for more papers by this author Yok-Lam Kwong,
Corresponding Author
Yok-Lam Kwong
Department of Medicine, Queen Mary Hospital, Hong Kong, China
Correspondence: Yok-Lam Kwong, M.D., Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China. Email:
[email protected]Search for more papers by this author
Thomas Cheng,
Thomas Cheng
Department of Radiology, Hong Kong Sanatorium Hospital, Hong Kong, China
Search for more papers by this author Florence Loong,
Florence Loong
Department of Pathology, Queen Mary Hospital, Hong Kong, China
Search for more papers by this author Yok-Lam Kwong,
Corresponding Author
Yok-Lam Kwong
Department of Medicine, Queen Mary Hospital, Hong Kong, China
Correspondence: Yok-Lam Kwong, M.D., Department of Medicine, Professorial Block, Queen Mary Hospital, Pokfulam Road, Hong Kong, China. Email:
[email protected]Search for more papers by this author
First published: 03 June 2013
No abstract is available for this article.
References
- 1Tsai EY, Taur A, Espinosa L et al. Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography. Arch Dermatol 2006; 142: 577–584.
- 2Feeney J, Horwitz S, Gönen M, Schöder H. Characterization of T-cell lymphomas by FDG PET/CT. AJR Am J Roentgenol 2010; 195: 333–340.
- 3Olsen EA, Whittaker S, Kim YH et al.; International Society for Cutaneous Lymphomas; United States Cutaneous Lymphoma Consortium; Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol 2011; 29: 2598–2607.
- 4Agar NS, Wedgeworth E, Crichton S et al. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol 2010; 28: 4730–4739.
- 5Adams MC, Turkington TG, Wilson JM, Wong TZ. A systematic review of the factors affecting accuracy of SUV measurements. AJR Am J Roentgenol 2010; 195: 310–320.
- 6Ansell SM, Armitage JO. Positron emission tomographic scans in lymphoma: convention and controversy. Mayo Clin Proc 2012; 87: 571–580.
